FY2027 EPS Estimates for ISRG Lowered by Erste Group Bank

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Research analysts at Erste Group Bank reduced their FY2027 earnings per share (EPS) estimates for Intuitive Surgical in a report issued on Tuesday, March 24th. Erste Group Bank analyst H. Engel now anticipates that the medical equipment provider will post earnings of $9.54 per share for the year, down from their prior forecast of $9.55. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

ISRG has been the subject of a number of other reports. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. The Goldman Sachs Group restated a “buy” rating and set a $714.00 price target on shares of Intuitive Surgical in a research note on Friday, January 9th. UBS Group cut their price target on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Finally, Raymond James Financial upped their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $468.55 on Friday. The business has a 50 day simple moving average of $496.15 and a 200 day simple moving average of $513.04. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $603.88. The stock has a market cap of $166.40 billion, a price-to-earnings ratio of 59.39, a PEG ratio of 3.63 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period last year, the business earned $2.21 EPS.

Institutional Investors Weigh In On Intuitive Surgical

A number of hedge funds have recently bought and sold shares of ISRG. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock valued at $15,026,776,000 after purchasing an additional 263,828 shares during the period. State Street Corp increased its position in Intuitive Surgical by 1.0% in the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after buying an additional 162,264 shares during the period. Capital World Investors increased its position in Intuitive Surgical by 1.7% in the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after buying an additional 127,526 shares during the period. Norges Bank acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $2,856,987,000. Finally, Invesco Ltd. lifted its holdings in shares of Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock worth $2,402,488,000 after buying an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, SVP Patricia L. Wadors sold 220 shares of the business’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the sale, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.